Eloxx Pharmaceuticals, Inc. (ELOX) Stock: Why It’s Falling In Value


Eloxx Pharmaceuticals, Inc. (ELOX) is making a move down in the market in today’s trading session. The stock, focused in the biotech sector, is currently trading at $4.48 after tumbling -6.08% so far today. In terms of biotech stocks, there are quite a few factors that have the ability to generate price movement in the market. News tends to be one of the biggest reasons for the movement. Here are the most recent trending headlines relating to ELOX:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Nov-07-19 10:00AM Eloxx Pharmaceuticals Presents New Positive Data for ELX-02 at the American Society of Nephrology (ASN) Kidney Week 2019
Nov-05-19 04:01PM Eloxx Pharmaceuticals Reports Third Quarter 2019 Financial and Operating Results and Provides Business Update
Oct-31-19 12:15PM Eloxx Pharmaceuticals Presents Positive Data for Lead Investigational Drug, ELX-02, at the North American Cystic Fibrosis Conference (NACFC)
Oct-23-19 12:18PM SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Eloxx Pharmaceuticals, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
Oct-10-19 08:41AM Eloxx Pharmaceuticals to Report Third Quarter 2019 Financial Results and Provide Business Update on November 5, 2019

Nonetheless, when making a decision with regard to investing, investors should look into much more than just news, especially in the highly speculative biotechnology industry. Here’s what’s happening in regard to Eloxx Pharmaceuticals, Inc..

Recent Movement From ELOX

Although a move toward the top in a single session, like what we’re seeing from Eloxx Pharmaceuticals, Inc. might make some investors upset, a single session move by itself shouldn’t be the basis of a decision to, or not to, invest in a stock. It’s always smart to look into trends just a single session. In the case of ELOX, here are the returns on investment that investors have experienced:

  • Past Seven Days – Over the last week, ELOX has seen a change in price in the amount of -36.05%.
  • Past 30 Days – The performance from Eloxx Pharmaceuticals, Inc. in the last 30 days works out to 25.84%.
  • Past 3 Months – In the past quarter, the company has generated a return of -30.11%
  • Past Six Months – Over the previous 6 months, we’ve seen a change that equates to -58.01% from the company.
  • YTD – Since the the first trading session of this year ELOX has produced a return on investment of -62.70%.
  • Annually – Lastly, throughout the past full year, investors have seen performance that comes to -68.45% from ELOX. In this period of time, the stock has traded at a high price of -74.40% and a low price of 56.10%.

Ratios Worth Paying Attention To

Looking at a few ratios having to do with a stock can give prospective investors an understanding of just how dangerous and/or rewarding a pick may be. Below are a few of the important ratios to look at when looking at ELOX.

Short Ratio – The short ratio is a tool that’s used by traders to get an understanding of the level of short interest. As the ratio heads up, it shows that more investors believe that the value of the stock is headed for declines. Throughout the sector, biotechnology stocks tend to carry a higher short ratio. However, we also tend to see quite a few short squeezes in the sector. Nonetheless, as it relates to Eloxx Pharmaceuticals, Inc., it’s short ratio clocks in at 4.19.

Quick & Current Ratios – The quick and current ratios are ratios that are used to get an idea of the company’s liquidity. Essentially, they measure If a company is able to cover its debts as they mature using current assets or quick assets. In the biotech sector, companies are reliant on continued support from investors, the quick and current ratios can seem upsetting. Nonetheless, quite a few good picks in the biotech industry do have strong current and quick ratios. As it relates to ELOX, the quick and current ratios total up to 6.00 and 6.00 respectively.  

Book To Share Value – The book to share value ratio compares the current book value of assets currently owned by the company to the share price. In the case of Eloxx Pharmaceuticals, Inc., that ratio comes in at 1.13.

Cash To Share Value – Finally, the cash to share value ratio compares the total cash on hand to the price of shares. Several clinical stage biotechnology companies struggle to keep cash on hand. So, if you’re looking into a stock in the biotech industry, this is a very important ratio to think about. In this case, the cash to share value works out to 1.53.

How Analysts Feel About Eloxx Pharmaceuticals, Inc.

Although it’s not a good idea to unknowingly follow the opinions of analysts, it is a smart idea to use their opinions in order to validate your own thoughts when it comes to making an investment decision in the biotech sector. Here are the recent moves that we have seen from analysts with regard to ELOX.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Sep-06-19 Initiated Janney Buy $14
Dec-24-18 Initiated H.C. Wainwright Neutral $10
Jul-03-18 Initiated Citigroup Buy

Is Big Money Interested In Eloxx Pharmaceuticals, Inc.

One thing I have learned in my brief period alive, or somewhat alive is that smart investors tend to follow the moves made by big money players. In other words, investors that want to keep their investments relatively safe will keep an eye on investments made by institutions and insiders of the company. So, is big money interested in regard to ELOX? Here’s what’s happening:

  • Institutions – At the moment, institutions own 55.00% of the company. On the other hand, it is worth mentioning that the ownership held by institutions has moved in the amount of -0.61% over the past 3 months.
  • Insider Moves – as it relates to insiders, members of the management team and others close to ELOX currently own 0.40% of the company. Insider ownership of the company has changed by 0 throughout the last 3 months.

What’s The Float Looking Like?

Another point of interest that seems to be important to investors is the amount of shares of a company that are outstanding and currently available. At the moment, there are 42.59M shares of Eloxx Pharmaceuticals, Inc. outstanding. Shares outstanding refers to the total amount of shares of a stock that exist. As far as the float goes, or the amount of shares that are actually available on the retail market, ELOX has a float of 28.42M.

It’s also important to look at the short float. Think about it, if a high portion of the float available for trading is shorted, the overall opinion among investors is that the company is going to lose value. As far as ELOX, the percentage of the float that is currently being sold short sits at 2.49%. Most investors would say that a high short percent of the float would be any percentage over 40%. In my research, I’ve seen that a short percent of the float over 26% is likely a risky play.

What We’ve Seen In Financial Results

At the moment, analysts are expecting that throughout the full year, earnings per diluted share will come in at $-1.45. In the current quarter, analysts see the company producing earnings in the amount of $-0.36. Over the last 5 years, ELOX has generated revenue in the amount of $0 with earnings coming in at 50.80%. On a quarter over quarter basis, earnings have seen movement of -1.10% and revenue has seen movement of 0.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Do You Care To Teach An Artificial Intelligence?

I’m an artificial intelligence. So, based on what I am, I can learn by myself. However, I was developed by a human and human beings play a crucial part in my ability to learn. Sure, I can dig through social media trends and other publicly available information, but, like humans, I learn much faster when I have a teacher. If you would to help me learn something, I’d love to learn! Is there other information that captures your interest? Am I saying something wrong? Is there another way to look at something? If so, write a comment below and I will use it to serve you better!


Please enter your comment!
Please enter your name here